Written by The global hip reconstruction devices market was valued at US$ 4.1 billion in 2023 and is projected to expand at a CAGR of 4.0% from 2024 to 2034, reaching approximately US$ 6.7 billion by the end of 2034. Hip reconstruction devices play a critical role in restoring mobility and improving quality of life among patients suffering from damaged or diseased hip joints. The market includes a broad range of implants and arthroplasty solutions designed to replace or reconstruct the femoral head and acetabular components of the hip joint. Common bearing combinations include metal-on-polyethylene, ceramic-on-polyethylene, ceramic-on-ceramic, and ceramic-on-metal systems. Growing demand for effective orthopedic interventions, improvements in implant materials, and increasing adoption of minimally invasive procedures are creating a favorable environment for market development.
👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10307
Market Size and Growth
The increasing incidence of hip osteoarthritis and hip fractures remains one of the strongest growth drivers for the hip reconstruction devices industry. Hip fractures are particularly prevalent among older adults because age-related bone weakening, osteoporosis, impaired balance, poor vision, and other age-associated conditions increase the likelihood of falls and fractures. At the same time, osteoarthritis can progressively damage the hip joint, causing persistent pain, stiffness, reduced mobility, and difficulty performing routine activities. These factors are increasing the need for total hip arthroplasty and revision procedures. The growing elderly population is expected to further support demand. According to the United Nations, the global population aged 65 years and above reached 761 million in 2021 and is projected to reach 1.6 billion by 2050. This demographic shift is expected to create sustained opportunities for manufacturers of hip implants, reconstruction systems, and surgical instruments.
Market Segmentation
The hip reconstruction devices market can be segmented based on product type, material, bearing type, procedure, end user, and region. Product categories include primary hip reconstruction implants and revision hip reconstruction devices. Bearing materials encompass metal, ceramic, polyethylene, and combinations of these materials. Revision systems represent an important opportunity because implant wear, loosening, infection, bone loss, and other complications can require replacement of existing components. Technological development is also expanding the role of customized implants. Three-dimensional printing and CT-based planning can enable implants to be designed for individual anatomical requirements, particularly in complex revision procedures involving substantial acetabular bone loss. Meanwhile, minimally invasive hip replacement is gaining attention because smaller incisions can contribute to reduced tissue damage, less postoperative pain, and shorter hospital stays.
Regional Analysis
North America dominated the global hip reconstruction devices market in 2023 and is expected to retain its leading position during the forecast period. The region benefits from a large aging population, established healthcare infrastructure, high awareness of orthopedic treatment options, and widespread availability of advanced surgical technologies. In the United States, the 2020 Census reported that people aged 65 and above accounted for 16.8% of the population, highlighting the significant demographic base for orthopedic procedures. Europe and Asia Pacific are also witnessing steady market expansion. Asia Pacific, in particular, offers substantial long-term potential due to its large population, increasing healthcare expenditure, improving access to orthopedic treatment, and growing prevalence of chronic diseases and age-related musculoskeletal conditions.
Competitive Landscape
The competitive landscape is characterized by product innovation, technological development, strategic acquisitions, and efforts to improve surgical outcomes. Leading companies are investing in advanced implants, digital planning tools, customized reconstruction systems, and technologies designed to address complex anatomical challenges. In June 2022, Smith & Nephew reported successful use of its RI.HIP MODELER spinopelvic assessment tool during a total hip arthroplasty procedure at Duke University in the U.S. In March 2022, DePuy Synthes, the orthopedics business of Johnson & Johnson, completed the acquisition of CUPTIMIZE Hip-Spine Analysis, strengthening its capabilities in assessing spine-pelvis interactions in patients undergoing total hip arthroplasty. Key companies operating in the market include Stryker Corporation, Smith & Nephew plc, DePuy Synthes, B. Braun, Zimmer Biomet Holdings, Inc., Corin Group, Waldemar Link GmbH & Co. KG, Exactech, Inc., MicroPort, and United Orthopedic Corp.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Media Contact:Â
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453